Here are 9 stocks that can benefit from Fed interest rate cuts

The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected consumer…

Jim Cramer says Nike should watch its back with Hoka running shoes doing so well

CNBC’s Jim Cramer sees footwear company Deckers Outdoor as a disruptive industry player that even big…

Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

We’re encouraged by an activist’s willingness to buy an Abbott rival, look past baby formula suits

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Here are the portfolio’s top 5 performers in a record-setting week for stocks

The bulls got what they wanted this week: cooler inflation data and record highs. The Dow…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving…

Abbott Labs’ surprise guidance bump is a major positive for its shareholders

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its…

Health care has had a tough year. Where we stand on our 5 stocks in the sector

There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the…

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this month,…

Here are the 8 trades and 3 price-target changes we made during a busy week

Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly results…

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the…

Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

Here’s what is behind the stock market’s sell-off and what we’re doing about it

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for…

Newseum Global